Douglas K. Bishop to Graft Rejection
This is a "connection" page, showing publications Douglas K. Bishop has written about Graft Rejection.
Connection Strength
1.882
-
Glucocorticoid-induced TNFR-related protein stimulation reverses cardiac allograft acceptance induced by CD40-CD40L blockade. Clin Dev Immunol. 2013; 2013:986859.
Score: 0.296
-
IL-6 promotes cardiac graft rejection mediated by CD4+ cells. J Immunol. 2011 Dec 01; 187(11):5764-71.
Score: 0.267
-
Role of T cell TGFbeta signaling and IL-17 in allograft acceptance and fibrosis associated with chronic rejection. J Immunol. 2009 Dec 01; 183(11):7297-306.
Score: 0.234
-
TGFbeta neutralization within cardiac allografts by decorin gene transfer attenuates chronic rejection. J Immunol. 2009 Dec 01; 183(11):7307-13.
Score: 0.234
-
OX40 costimulation prevents allograft acceptance induced by CD40-CD40L blockade. J Immunol. 2009 Jan 01; 182(1):379-90.
Score: 0.220
-
CD8+ Th17 mediate costimulation blockade-resistant allograft rejection in T-bet-deficient mice. J Immunol. 2008 Sep 15; 181(6):3906-14.
Score: 0.216
-
Requirement for donor and recipient CD40 expression in cardiac allograft rejection: induction of Th1 responses and influence of donor-derived dendritic cells. J Immunol. 2004 Jun 01; 172(11):6626-33.
Score: 0.160
-
Transient blockade of delta-like Notch ligands prevents allograft rejection mediated by cellular and humoral mechanisms in a mouse model of heart transplantation. J Immunol. 2015 Mar 15; 194(6):2899-908.
Score: 0.084
-
Recipient-derived EDA fibronectin promotes cardiac allograft fibrosis. J Pathol. 2012 Mar; 226(4):609-18.
Score: 0.068
-
Transforming growth factor-beta1 gene transfer is associated with the development of regulatory cells. Am J Transplant. 2005 Oct; 5(10):2378-84.
Score: 0.044
-
The immunobiology of inductive anti-CD40L therapy in transplantation: allograft acceptance is not dependent upon the deletion of graft-reactive T cells. Am J Transplant. 2002 Apr; 2(4):323-32.
Score: 0.034
-
Anti-CD40L monoclonal antibody treatment induces long-term, tissue-specific, immunologic hyporesponsiveness to peripheral nerve allografts. J Reconstr Microsurg. 2008 Apr; 24(3):189-95.
Score: 0.013
-
Short-term anti-CD40 ligand costimulatory blockade induces tolerance to peripheral nerve allografts, resulting in improved skeletal muscle function. Plast Reconstr Surg. 2006 Jun; 117(7):2250-8.
Score: 0.011